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Abstract
Background—A considerable amount of research has been published about genetic hearing 
impairment. Fifty to sixty percent of hearing loss is thought to have a genetic cause. Genes may 
also play a significant role in acquired hearing loss due to aging, noise exposure, or ototoxic 
medications. Between 1995 and 2012, over 100 causative genes have been identified for 
syndromic and nonsyndromic forms of hereditary hearing loss (see Hereditary Hearing Loss 
Homepage http://hereditaryhearingloss.org). Mouse models have been extremely valuable in 
facilitating the discovery of hearing loss genes, and in understanding inner ear pathology due to 
genetic mutations or elucidating fundamental mechanisms of inner ear development.
Purpose—Whereas much is being learned about hereditary hearing loss and the genetics of 
cochlear disorders, relatively little is known about the role genes may play in peripheral vestibular 
impairment. Here we review the literature with regard to genetics of vestibular dysfunction and 
discuss what we have learned from studies using mutant mouse models and direct measures of 
peripheral vestibular neural function.
Results—Several genes are considered that when mutated lead to varying degrees of inner ear 
vestibular dysfunction due to deficits in otoconia, stereocilia, hair cells, or neurons. Behavior often 
does not reveal the inner ear deficit. Many of the examples presented are also known to cause 
human disorders.
Conclusions—Knowledge regarding the roles of particular genes in the operation of the 
vestibular sensory apparatus is growing and it is clear that gene products co-expressed in the 
cochlea and vestibule may play different roles in the respective end organs. The discovery of new 
genes mediating critical inner ear vestibular function carries the promise of new strategies in 
diagnosing, treating and managing patients as well as predicting the course and level of morbidity 
in human vestibular disease.
Keywords
Genetics; vestibular; vestibular evoked potentials; mutant mouse models; hereditary vestibular 
disorders
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Prevalence and relationship between heritable auditory and vestibular 
disorders in humans
The inner ear houses the sensory organs responsible for hearing and balance. The organ of 
Corti within the cochlea transduces sound and initiates sensory signals underlying hearing. 
Vestibular receptors within the two maculae and three ampullae transduce linear or angular 
motion of the head, respectively. Deficits in one or more of these inner ear end organs or 
their neural innervation can lead to hearing loss, vestibular dysfunction, or both. Hearing 
loss due to peripheral injury most commonly is represented as elevated hearing thresholds at 
particular frequencies, which may or may not be accompanied by altered oto-acoustic 
emissions. Vestibular dysfunction may be manifested in many ways including abnormal 
posturing and imbalance, rhythmic eye movements (nystagmus), abnormal vestibulo-ocular 
reflexes (VOR), abnormal vestibulo-collic reflexes (VCR), and/or reports of disorientation, 
altered subjective vertical, spinning sensations, dizziness, nausea, and blurred vision. Unless 
otherwise stated, the designation of “vestibular dysfunction”, ..disorder”, …impairment” 
etc., throughout this review is meant to imply a peripheral functional loss involving 
vestibular sensors and/or eighth nerve. In this case there is either direct functional or 
structural evidence or strong indirect evidence for involvement of the peripheral vestibular 
system. Examples of direct evidence would include anatomical or physiological measures of 
the peripheral end organs or vestibular nerve. Examples of strong indirect evidence might 
include absent VOR or caloric responses.
One to three per 1000 children are born with severe to profound hearing impairment and 
many others develop significant hearing impairment before adulthood. The percentage of 
adults with hearing impairment increases with advanced age and a significant portion of age 
related hearing loss (as much as 30%) is thought to have a genetic cause (see reviews by 
Nadol and Merchant, 2001; Petersen, 2002). Over 400 syndromes with associated hearing 
loss have been described (Toriello et al., 2004). Nearly 100 chromosomal loci have been 
identified for nonsyndromic hearing loss with genes identified for over 40 forms (Van Camp 
and Smith, Hereditary Hearing Loss Homepage: http://hereditaryhearingloss.org; also see 
reviews by Nadol and Merchant, 2001; Petit et al., 2001; Petersen, 2002; Bitner-Glindzicz, 
2002).
While much is being learned about the genetics of hearing loss, relatively little is known 
about the role genes may play in vestibular impairment. Estimates of vestibular dysfunction 
range from around 30 to 90% among children with hearing impairment of various causes 
(Shinjo et al. 2007; Steel, 1991; Tribukait et al., 2004; Zhou et al., 2009) and 34% among 
children with hereditary hearing impairment (Arnvig, 1955). Not all genetic mutations 
produce both cochlear and vestibular abnormalities. The heterogeneity of Usher syndrome is 
one example. Retinal degeneration and auditory impairment are common to Usher 
Syndrome, but vestibular function varies considerably (e.g., see reviews by Keats and 
Corey, 1999; Keats, 2002; Van Camp and Smith, Hereditary Hearing Loss Homepage: 
http://hereditaryhearingloss.org). Usher Type I syndrome, due to mutations in a variety of 
genes including MYO7A (myosin 7A), USH1C (harmonin), CDH23 (cadherin 23), or 
PCDH15 (protocadherin 15), has profound inner ear vestibular deficits. Usher Type II 
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syndrome, due to USH2A (usherin) mutations, does not show vestibular deficits (at least to 
the extent that vestibular function has been tested and reported in the literature), and Usher 
Type III syndrome, due to mutations in CLRN1 (Clarin 1) shows variable vestibular 
dysfunction [See summary in Table 1]. DFNA9, one form of nonsyndromic hereditary 
hearing loss, caused by mutations in the COCH gene, has also been reported to have variable 
inner ear vestibular dysfunction (Robertson et al., 2008). Therefore, depending upon the 
gene and the protein encoded by that gene, along with other factors, vestibular dysfunction 
may accompany peripheral cochlear impairment and hearing loss or it may not.
Considering the large number of genes identified for hearing loss, it is noteworthy that no 
genetic causes for nonsyndromic peripheral vestibulopathies have been identified in humans 
(Jen, 2011; Eppsteiner and Smith, 2011; Gazquez and Lopez-Escamez, 2011). A few central 
disturbances in balance or motor control such as episodic ataxia or spinocerebellar ataxia 
have been linked to neuronal genes KCNA1 (encodes a voltage-gated potassium channel) 
and CACNA1 (encodes the α1A subunit of a voltage-gated calcium channel; Gazquez and 
Lopez-Escamez, 2011; Baloh, 2012; Jen, 2008). Studies on peripheral vestibular disorders 
such as Menière’s disease or bilateral vestibular hypofunction have reported no definitive 
genetic linkage (Birgerson et al, 1987; Frykholm et al, 2006; Klockars and Kentala, 2007). 
Could there be a genetic basis for peripheral vestibular disorders? Additionally, are there 
individuals wherein a peripheral vestibular impairment goes undetected because of 
compensation or adaptation by the central nervous system? Peripheral vestibular dysfunction 
has been implicated as a potential cause of delayed motor development (e.g., Takiguchi et 
al., 1991; Tsuzuku and Kaga, 1992; Admiraal and Huygen, 1997; Kaga, 1999; Rine et al., 
2000). However, the subjects in a number of these studies also had deficits in other systems 
(e.g., hearing loss, brain injury), which makes it difficult to evaluate the consequences of 
peripheral vestibular dysfunction independently. The potential correlation is compelling 
nonetheless and suggests the need for further studies of genetic vestibular deficits.
Basis for our meager understanding of genetic vestibular disorders
There are several reasons for the paucity of data regarding hereditary vestibular impairment. 
First, peripheral vestibular dysfunction in humans is difficult to assess directly. Current 
clinical tests of vestibular function evaluate the final motor output of control systems that 
maintain eye position or postural balance during movement. Such measures encompass the 
input, integration and output components of nervous system function, making it more 
difficult to ascertain the functional status of the vestibular periphery and then correlate 
function with genetic data. Second, relatively few investigators are systematically looking 
for vestibular impairment in human or animal genetic studies. Vestibular assessment is often 
not part of routine phenotyping in suspected cases of hereditary abnormalities or broad scale 
studies of genetic mouse mutants. Third, if peripheral vestibular impairment is present at 
birth or deficits appear gradually, the central nervous system likely compensates for the 
altered vestibular sensory input rendering any deficit undetectable via case histories, 
questionnaires or gross behavioral observations. In cases where motor delays, imbalance, or 
abnormal postural behaviors are apparent, vestibular function is often not tested as a 
possible etiology so the functional status of the vestibular periphery remains unknown.
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Approaches for the direct study of vestibular function
Direct measures of peripheral vestibular function are available for use in animal models. 
Measuring the discharge patterns of single primary afferent neurons in response to head 
motion is an excellent direct approach to use. The study of isolated vestibular hair cells is 
also a powerful direct approach. These and other methods require surgical access to 
vestibular structures and the resources required for such studies often restrict their general 
use in genetic studies. The relative simplicity of far-field recording of vestibular compound 
action potentials lends them to more general use; particularly for an initial general 
assessment of peripheral vestibular function in genetically altered or mutant animals, 
especially mice. The vestibular sensory evoked potential (VsEP) is one such measure. The 
VsEP should not be confused with the vestibular-evoked myogenic potential (VEMP). The 
VEMP is an electrical recording of muscle activity that is modulated by vestibulo-spinal 
reflex circuits and thus is an indirect measure of peripheral vestibular function. Linear 
VsEPs provide a direct measure of peripheral vestibular function because they are 
compound action potentials generated by the vestibular portion of the eighth nerve and 
central vestibular relays in response to transient linear acceleration of the head. The neural 
responses can be recorded from the surface of the skull much like the widely used auditory 
brainstem response (ABR, e.g., Jones, 1992; Jones and Jones, 1996, 1999; also see reviews 
by Jones and Jones, 2007; Jones, 2008). VsEP response waveforms consist of a series of 
three or more positive and negative peaks that occur within 8 to 10 ms after stimulus onset. 
Intense acoustic masking or cochlear extirpation does not affect responses, but they 
disappear after death, bilateral surgical labyrinthectomy, or pharmacological blockade of the 
eighth nerve (Jones and Pedersen, 1989; Jones, 1992; Jones and Jones, 1999). The earliest 
response components reflect activity of the peripheral vestibular nerve whereas later 
response peaks reflect activity of vestibular relays within the brainstem and higher centers 
(Jones, 1992; Nazareth and Jones, 1998). The cerebellum does not contribute significantly to 
the mammalian VsEP (Gaines, 2012). In mammals, our laboratory has shown that linear 
VsEPs depend strictly upon the utricle and saccule (also known as the otolithic organs or 
gravity receptors) of the inner ear (Jones et al., 1999). Furthermore, linear VsEP amplitudes 
are directly proportional to the amount of otoconia present in macular organs (Jones et al., 
2004) and response thresholds are inversely related to the density of hair cell synaptic 
elements in the macular neuroepithelium (Pierce, 2012). The VsEP has been useful in 
studying vestibular development, aging, plasticity, pharmacology, and genetics, and will 
likely find many other uses as it comes into more general use.
Another useful but indirect measure of vestibular function is the vestibulo-ocular reflex 
(VOR). It provides an objective quantitative measure of the reflex arc mediated primarily by 
horizontal canal afferents, central vestibular neural relays and motor outflow to the 
extraocular muscles. The reflex serves to control the position of the eyes in the head in order 
to maintain gaze on a particular object in the visual scene during horizontal rotation of the 
head. Measurement of the VOR in rodents is challenging, but several laboratories have 
developed the method for use in mice (e.g., Beraneck et al., 2012, Stahl et al., 2000; 2006; 
van Alphen et al., 2001). Some of the attributes of this approach include the ability to 
quantify the behavior of a vestibular reflex and characterize the combined effects of changes 
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in peripheral afferent and efferent function as well as in central processing of vestibular 
sensory input. The disadvantage of this approach is that vestibular deficits may be masked 
by central plastic changes and ultimately compensation for peripheral vestibular loss. The 
combined use of the VOR and direct measures of peripheral vestibular function presumably 
would be most effective and provide a means to distinguish changes in central relays and 
motor outflow from changes in vestibular sensory input (e.g., Alagramam et al., 2005).
Learning about genetic vestibular impairment from mouse models
The mouse has a long history as a genetic model for hearing loss and imbalance behaviors 
(e.g., Yerkes, 1907; Lord and Gates, 1929; Lyon, 1953; Deol, 1954; see also Ruben, 1991; 
Steel and Brown, 1994; Steel, 1995; Lyon et al., 1996; Petit et al., 2001; Ahituv and 
Avraham, 2002). Many early studies described behaviors characteristic of imbalance such as 
head bobbing, circling, hyperactivity, and such behaviors have often been attributed solely 
to inner ear dysfunction. Behavior alone is often a poor indicator of inner ear function. 
Imbalance behaviors may be due to deficits at a variety of levels of the neuraxis or may even 
be due to muscular deficits. In addition, behavior may be completely normal despite the 
presence of profound deficits in the inner ear.
Genetic mouse models wherein peripheral vestibular function and morphology have been 
quantified have proven to be quite powerful in shedding light on the role of genes in inner 
ear vestibular function. Indeed, structural investigations of the vestibular system in mutant 
mice have identified or further characterized structural defects in otoconia (e.g., Lyon, 1953; 
Lyon and Meredith, 1969; Rauch, 1979; Trune and Lim, 1983; Erway and Grider, 1984; 
Bergstrom et al., 1998; Jones et al., 2004), stereociliary bundles (e.g., Avraham et al., 1995; 
Moriyama et al., 1997; Di Palma et al., 2001; Alagramam et al., 2001; 2005), hair cells (e.g., 
Deol, 1954; Anniko et al., 1980; Dememes and Sans, 1985; Wenngren and Anniko, 1989; 
Sjostrom and Anniko, 1990; Kitamura et al., 1991; Otani et al., 1995; Kozel et al., 1998; Ma 
et al., 2000), inner ear pigment (Cable et al., 1994, 1995), and vestibular ganglion (e.g., 
Ernfors et al., 1995; Liebl et al., 1997; Ma et al., 2000).
Recent work has clarified the role of widely recognized genes (as noted above) in the 
vestibular periphery as well as brought to light new genes underlying vestibular function. 
We review here several examples of genes and gene products contributing to peripheral 
vestibular function, specifically macular receptor function that we have studied. In the 
discussion that follows, the reader may notice a different representation for the gene names. 
Human genes are represented by non-italicized upper case letters as used in the above 
discussion. Mouse genes are written with italicized upper and lower case letters. Protein 
products may appear as the gene name, but are not italicized. Table I summarizes general 
features of genes discussed.
Mutations affecting otoconia
Many altered genes produce a loss of otoconia and a corresponding loss of macular receptor 
function. Several genes have proven to be critical for the formation of otoconia [e.g., Nox3 
(NADPH oxidase 3, Paffenholz et al., 2004), Otop1, (otopetrin 1, Hurle et al., 2003) Slc30a4 
(solute carrier family 30 member 4, Huang and Gitschier 1997), Pldn (pallidin, Hermansky-
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Pudlak Syndrome, Huang et al., 1999), Cyba (Cytochrome b-245 light chain (p22phox), 
Nakano et al., 2008). In the absence of otoconia, responses to linear translation are absent 
(figure 1, Jones et al., 1999; 2004; 2008). This is the case despite an otherwise intact sensory 
apparatus including the normal complement of type I and type II vestibular hair cells, ribbon 
synapses and corresponding calyceal, dimorph and bouton primary afferent terminals 
(Hoffman et al., 2006; 2007a; 2007b). Although neural responses to head translation are 
absent, macular primary afferent spontaneous activity is normal in some otoconia deficient 
animals (Jones et al., 2008). Moreover, responses of ampullar primary afferents to head 
rotation (Jones et al., 2008; Harrod and Baker, 2003) and cochlear responses to sound are 
preserved (figure 1).
There can also be significant behavioral consequences with the absence of otoconia. General 
postures and locomotion in otoconia deficient mice appear relatively normal although an 
“experienced eye” might note altered static head positions (tilting) in some animals. 
However, because animals lacking otoconia cannot sense the direction of the gravity vector, 
they cannot swim normally, and they are easily disoriented in water losing all sense of up 
and down. In some cases, otoconial loss is graded and compound neural responses to head 
translation (i.e., VSEPs) in these cases varies in direct proportion to the amount of otoconia 
preserved (Jones et al., 2004). One interesting observation has been that in the presence of 
even small amounts of otoconia and reduced VsEP responses to translation, behavioral 
measures remain normal or near normal (e.g., Ornitz et al., 1998; Zhao et al., 2008; Jones et 
al., 2004). Indeed, from our experience, it appears that even the least bit of peripheral 
sensory input from the maculae provides a sufficient sensory cue to the central nervous 
system to support normal behaviors requiring detection of the gravity vector (e.g., 
swimming).
Identification of genes critical for the formation of normal otoconia provides insight into the 
basic mechanisms underlying the formation and maintenance of otoconia (e.g., Zhao et al., 
2007; Nakano et el., 2008). Moreover, in some cases human genetic homologs have been 
identified thus shedding light on mechanisms underlying human disease. One example is 
seen in a report by Nakano et al, (2008). The protein p22phox forms the central enzymatic 
core of the NADPH oxidase complex found primarily in cells of the endolymphatic duct and 
sac. In the human, mutations in CYBA (the gene that encodes p22phox) leads to a serious 
immune disorder called chronic granulomatous disease (CGD), which is related to the 
inability to generate reactive oxygen species in defense of invading pathogens. Nakano and 
coworkers reported that the absence of p22phox leads to major otoconial dysgenesis and 
absent VsEPs. These and other findings led to the proposal that during development, 
NADPH oxidases produce superoxide, which in turn acts to increase pH levels and Ca2+ 
concentration within the embryonic endolymph. Increased (alkaline) pH and elevated Ca2+ 
concentrations are physical requirements for the crystallization of calcium carbonate and 
formation of otoconia (Nakaya et al., 2007; Chou et al., 1989). Such conditions are not 
present in the endolymph of an adult and thus must be present during development when 
otoconia form. Hypothetically, in the absence of a functional NADPH oxidase complex 
these conditions are not met and otoconia do not form.
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Mutations affecting stereocilia and hair cells
Hair cell stereociliary bundles are critical for transduction and encoding of vestibular and 
auditory stimuli. They represent complex elaborate specializations located at the apical 
surface of the hair cell. The hair bundle is held together by many extracellular protein links 
that connect adjacent stereocilia. These include tip links, shaft links, ankle links, lateral 
links, and kinocilial links (Nayak et al., 2007). At least 18 genes have been identified as 
components of the stereocilary bundle. Genetic mutations leading to the deletion of 
stereociliary proteins generally lead to hair cell dysfunction and deafness. Examples include 
genes associated with human Usher syndrome (MYO7A, CDH23, PCDH15, Bork et al., 
2001, Ahmed et al., 2001; Alagramam et al., 2001) and many others (see Hereditary Hearing 
Loss Homepage; http//heriditaryhearingloss.org). Deletion of the receptor-like inositol lipid 
phosphatase, Ptprq (Oganesian et al., 2003), produces a progressive loss of auditory 
function in mice. The protein phosphatidylinositol phosphatase (PTPRQ) forms part of the 
shaft links and genetic deletions produce hair cell bundle defects, loss of hair cells in the 
base of the cochlea and deafness (Goodyear et al., 2003). These studies in mice reported no 
overt vestibular behaviors or structural damage although auditory dysfunction was clearly 
evident (a nonsyndromic deafness). More recent work (Goodyear et al., 2012) also reported 
the absence of overt behavioral signs of vestibular deficits. Only subtle changes in 
swimming behaviors were noted. However, VsEPs, (figure 2) indicated severe to profound 
macular receptor dysfunction and detailed structural studies revealed significant stereociliary 
bundle defects in the vestibular maculae. These findings reflect the important role Ptprq 
plays in maintaining normal vestibular stereociliary bundles and vestibular function. In 
humans, mutations in PTPRQ cause autosomal, non-syndromic recessive deafness 
(DFNB84, Schraders et al., 2010; Shahin et al., 2010). Of interest is the observation that 
some DFNB84 families reportedly had vestibular deficits, which may be understood and 
explained by findings in Ptprq mutant mice.
Protocadherin 15 is a protein constituent of kinociliary links and stereociliary tip links of 
hair cell stereociliary bundles (e.g., Goodyear et al., 2010; Gillespie and Muller 2009). 
Spontaneous mutations in the protocadherin 15 gene (PCDH15) produce profound auditory 
and vestibular deficits in both humans (Ahmed et al., 2003; Ben-Yosef et al., 2003) and 
animals (Alagramam et al., 2001; Alagramam et al., 2005). Milder forms of inner ear 
deficits have been produced in mice by removing specific coding segments of the Pcdh15 
gene (e.g., exons 35, 38 and 39, Webb et al., 2011). Removing exon 38 for example, resulted 
in profound auditory deficits but spared vestibular function based on VOR testing. Such 
experiments reveal the complexities of hair cell stereociliary bundle structures and the subtle 
but remarkable differences that exist between auditory and vestibular hair cells. It is 
interesting that VOR testing was normal in these animals despite the absence of kinociliary 
links and presence of other vestibular morphological abnormalities. It would be of interest to 
evaluate these animal models using a direct measure of peripheral vestibular function, which 
may reveal a peripheral loss corresponding with the structural anomalies.
As previously mentioned, Usher syndrome presents as congenital deafness and blindness 
(Petit, 2001). The distinction among the different types of Usher Syndrome in large part 
depends on the severity of hearing loss and presence of vestibular deficit. Usher Type 3 
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manifests as a variable loss of vestibular function and progressive hearing loss. The exact 
function of the CLRN1 gene is unknown but in the human, loss of CLRN1 function is 
associated with Usher Syndrome 3A (USH3A) an autosomal recessive disorder, which 
manifests as a progressive loss of hearing and variable vestibular loss of function. In mice, 
the Clrn1 gene is expressed in hair cells and primary afferent ganglia of the vestibular and 
auditory end organs (Geng et al., 2009), an observation that is consistent with a role in 
peripheral hearing and vestibular function. In the Clrn1 knockout mouse, auditory function 
degrades rapidly after birth and is absent by postnatal day 30. This is accompanied by severe 
structural changes in the cochlea including the loss of almost all cochlear hair cells as well 
as degradation of basal supporting cells. Behavioral evidence of vestibular dysfunction 
(swimming tests, general behavioral observations) is subtle and equivocal at ages younger 
than 90 days. By the age of 6 months, behavioral signs such as head bobbing become more 
apparent in Clrn1 kockout animals. On the other hand, VsEPs indicated an early loss of 
function between postnatal day 14 and 30 characterized by increased thresholds and 
prolonged latencies (figure 3) suggesting altered hair cell or primary afferent function. 
Clearly these findings indicate that Clrn1 is critical for normal auditory and vestibular 
function in both the mouse and human, and the nature of inner ear loss of function is 
comparable to that shown in USH3A. The Clrn1 mouse model may prove helpful in finding 
the functional role of the gene and in understanding the basis of USH3A.
Mutations affecting hair cell synapses
The synaptic apparatus of hair cells is essential for the activation of primary afferent neurons 
and the encoding of the physical characteristics of a sound or head motion into neural 
discharge patterns. Synaptic transmission in the hair cell involves a structure called the 
synaptic ribbon. Synaptic vesicles containing neurotransmitter are initially tethered to the 
synaptic ribbon and then docked to the plasma membrane in the active zone. In the presence 
of Ca2+, docked vesicles fuse with the cell membrane and release neurotransmitter (i.e., 
glutamate) into the extracellular synaptic space; a process called exocytosis. Transmitter 
release increases when transduction currents depolarize the hair cell, which activates voltage 
sensitive Ca2+ channels near the active zones of ribbon synapses. Local increases in Ca2+ 
trigger exocytosis. Otoferlin (Otof) is a protein associated with the membranes of synaptic 
vesicles. It is believed to be a Ca2+sensor and when activated, otoferlin facilitates fusion of 
docked vesicles at the active zone. The presence of otoferlin and its contribution to auditory 
hair cell function has been appreciated for some time (Yasunaga et al., 1999; Roux et al., 
2006). Mutations of otoferlin in humans cause nonsyndromic deafness, DFNB9. Otof mutant 
mice evidence defective Ca2+-dependent exocytosis and severely impaired hearing (Roux et 
al., 2006; Beurg et al., 2008). Otoferlin is found associated with synaptic vesicles in both 
type I and II vestibular hair cells (Dulon et al., 2009; Yasunaga et al, 1999; Roux et al., 
2006; Schug et al., 2006). The functional role of otoferlin in vestibular sensors has also been 
evaluated using the Otof mouse model (Dulon et al., 2009). In the absence of Otof, VsEPs 
evidence significantly elevated thresholds, prolonged latencies and decreased amplitudes 
(figure 4), findings consistent with a substantial presynaptic defect causing slowed or 
reduced Ca2+-dependent transmitter release. Additional direct measurements of spontaneous 
primary afferent discharge and dendritic excitatory postsynaptic potentials revealed no 
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changes in spontaneous activity. However, Ca2+-dependent exocytosis in vestibular hair 
cells was markedly impaired, more so in Type I than Type II hair cells. Moreover, the 
normal linear relationship between Ca2+ flux and the rate of exocytosis was dramatically 
reduced and transformed into a shallow nonlinear function. All of these dramatic functional 
changes in the absence of Otof occurred despite the appearance of structurally normal 
vestibular ribbon synapses. Thus otoferlin appears to be of critical importance to normal 
synaptic transmission in both auditory and vestibular hair cells. Given these substantial 
effects, it is remarkable that there is no apparent vestibular deficits in the gross behavior of 
Otof mutant mice (Roux et al., 2006; Schwander et al., 2007).
Mutations affecting ionic homeostasis
Human corneal hereditary dystrophy type 2 (CHED2) and Harboyan syndrome are caused 
by mutations in the SLC4A11 gene, the symptoms of which include corneal defects, 
nystagmus and hearing loss. Little was known regarding the functional role of this gene until 
recently. Moreover, the underlying etiology for these symptoms was unclear. Park et al. 
(2004) showed that the gene product of SLC4A11 was a sodium-coupled borate 
cotransporter, which is a pump that moves the borate ion across the cell membrane using the 
energy supplied by the sodium concentration gradient. Lopez et al. (2009) showed that 
SLC4A11 is expressed in fibrocytes of the cochlea and inner ear vestibular system as well as 
in other tissues including the cornea and may serve some role in postassium recycling. To 
investigate the role of the of the sodium coupled borate cotransporter in the cornea and inner 
ear of mice, Lopez and colleagues (2009) generated an Slc4a11 mutant mouse model. 
Although behavior was normal in Slc4a11 mutant mice, deficits in both ABR and VsEPs 
were evident. Figure 5 illustrates vestibular functional deficits in Slc4a11 mice. Latencies of 
N1 of the VsEP were prolonged suggesting prolonged conduction times in the eighth nerve. 
Moreover, amplitudes of the eighth nerve response parameter (P1-N1) were significantly 
reduced and the slope of the relationship between amplitude and stimulus level was 
essentially flat. Interestingly, changes in P2 and N2 suggested central deficits as well as 
peripheral. In addition, the absence of the cotransporter resulted in remarkable structural 
changes in the vestibule including collapse of the membranous labyrinth and subtle corneal 
structural changes. Swelling or collapse of the membranous labyrinth suggest altered fluid 
balance and that the Slc4a11 mutant mouse may serve as a new model for the study of 
hydrops and labyrinth fluid homeostasis in addition to CHED2 and Harboyan syndromes. 
Moreover, these findings suggest the possibility of an underlying occult vestibular deficit in 
patients with CHED2 and Harboyan syndrome and may explain reports of nystagmus in 
some patients.
Although it is not clear how the absence of Slc4a11 causes inner ear dysfunction, it is 
reasonable to hypothesize that the cotransporter plays an important role in maintenance of 
normal fluid balance and electrolyte homeostasis. Transport mechanisms in fibrocytes of the 
inner ear have been shown to be essential for inner ear function and potassium recycling 
(e.g., Zdebik et al 2009). The loss of Slc4a11 in fibrocytes may interfere with inner ear 
homeostatic mechanisms through some as yet unknown mechanism.
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Summary
Knowledge regarding the roles of particular genes in the operation of the peripheral 
vestibular sensory apparatus is growing and it is clear that gene products co-expressed in the 
cochlea and vestibule may play very different roles, including no functional role, in the 
respective structures. Historically, vestibular deficits often missed detection owing to 
intended focus on other sensory modalities or the inherent difficulty in making objective 
direct vestibular assessments. Powerful direct measures of vestibular function are available 
and, when used in combination with measures of behavior and VOR, can provide a 
considerable amount of detail regarding peripheral defects as well as central compensation 
for peripheral deficits. The discovery of new genes mediating critical peripheral vestibular 
function carries the promise of new strategies in diagnosing, treating and managing patients 
as well as predicting the course and level of morbidity in human vestibular disease.
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Abbreviations
VsEP vestibular evoked potentials
VOR vestibulo-ocular reflex
MYO7A myosin 7A
CDH23 cadherin 23
PCDH15 protocadherin 15
NOX3 NADPH oxidase 3
OTOP1 otopetrin 1
SLC30A4 solute carrier family 30 member 4
PLDN pallidin
CYBA Cytochrome b-245 light chain (p22phox)
PTPRQ protein-tyrosine phosphatase, receptor-type, Q
OTOF otoferlin
ABR auditory brainstem response
CLRN1 clarin 1
USH2A usherin
USH1C harmonin
KCNA1 potassium voltage-gated channel subfamily A member 1
CACNA1 voltage-dependent P/Q-type calcium channel subunit alpha-1A
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SLC4A11 solute carrier family 4 member 11
CHED2 corneal endothelial dystrophy 2
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Figure 1. 
Photomicrographs (left) of a section through the utricle of one normal mouse (C57BL/6J) 
and one mutant mouse B6Ei.GL-Nox3het/J. The normal mouse exhibits darkly stained 
otoconial matrix (arrows), while the Nox3 mutant mouse does not possess any stained 
otoconial matrix (arrows). On the right are representative auditory brainstem responses 
(ABR) and vestibular evoked potentials (VsEP) for the two mouse strains. Both strains 
exhibit normal auditory function as measured by ABR. Normal mice exhibit robust VsEPs. 
The Nox3 mice with complete loss of otoconia have absent VsEPs. From Hearing Research, 
135, Jones SM, Erway LC, Bergstrom RA, Schimenti JC, Jones TA. Vestibular responses to 
linear acceleration are absent in otoconia-deficient C57BL/6JEi-het mice, 56–60, 1999, with 
permission from Elsevier.
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Figure 2. 
Representative VsEP waveforms recorded at the maximum stimulus level (+6 dB re: 1.0 
g/ms) for nine Ptprq+/− and nine Ptprq−/− mice (A). Most Ptprq+/− mice show robust 
responses; however, a few show reduced amplitudes. Ptprq−/− mice have variable function 
with several showing absent VsEPs or VsEPs with reduced amplitudes, prolonged latencies, 
and elevated thresholds. From Goodyear et al., (2012).
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Figure 3. 
Mutations in clarin1 are responsible for Usher Type 3 syndrome characterized by profound 
hearing loss, blindness, and variable vestibular function. VsEPs in Clrn1 mouse strain show 
VsEPs with significantly prolonged latencies, reduced amplitudes, and elevated thresholds. 
From Geng R, Geller SF, Hayashi T, Ray C, Reh TA, Bermingham-McDonogh O, Jones 
SM, Wright CG, Imanishi Y, Palczewski K, Alagramam KN, Flannery JG. Usher syndrome 
IIIA gene clarin-1 is essential for hair cell function and associated neural activation. Human 
Mol. Genet., 2009, 18(15), 2756 with permission of Oxford University Press.
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Figure 4. 
Otoferlin, a membrane bound protein found in association with the synaptic ribbon, is 
essential for normal exocytosis and synaptic transmission between the sensory hair cell and 
the primary afferent neurons. Otoferlin mutations result in profound hearing loss. Otoferlin 
has also been shown to be critical for vestibular type I hair cells, but vestibular function is 
not completely lost. Otof mutant mice show altered latency-intensity and amplitude-intensity 
functions. From Dulon et al., (2009).
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Figure 5. 
Slc4a11 mutations cause Harboyan Syndrome. VsEPs in Slc4a11 mutant mice show 
dramatically altered waveform morphology with large broad response peaks, and prolonged 
latencies. VsEP thresholds are unaffected. ABR waveforms (not shown) also show 
prolonged latencies. This research was originally published in the Journal of Biological 
Chemistry. Lopez IA, Rosenblatt MI, Kim C, Galbraith GC, Jones SM, Kao L, Newman D, 
Liu W, Yeh S, Pushkin A, Abuladze N, Kurtz I. Slc4a11 gene disruption in mice, cellular 
targets of sensorineuronal abnormalities. Journal of Biological Chemistry. 2009; 284: 
26882–26896. © the American Society for Biochemistry and Molecular Biology.
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Table 1
Genes discussed in the text that have strong evidence for peripheral vestibular dysfunction. Most of these 
genes are known to cause significant hearing impairment in humans as indicated by the human disorders 
listed. The peripheral vestibular involvement represents evidence from human or mouse studies as indicated.
Gene Protein Human Disorder Peripheral Vestibular Involvement
MYO7A Myosin 7A Usher Type 1B Yes (human and mouse)
USH1C Harmonin Usher Type 1C Yes (human and mouse
CDH23 Cadherin 23 Usher Type 1D Yes (human and mouse)
PCDH15 Protocadherin 15 Usher Type 1F Yes (human and mouse)
USH2A Usherin Usher Type 2A No (human)
CLRN1 Clarin 1 Usher Type 3A Variable (human and mouse)
COCH Cochlin DFNA9 Variable (human and mouse)
KCNA1 Potassium voltage-gated channel subfamily 
A member 1
Episodic Ataxia Type1 Unknown
CACNA1A Voltage-dependent P/Q-type calcium 
channel subunit alpha-1A
Episodic Ataxia Type2
Spinocerebellar Ataxia
Unknown
NOX3 NADPH oxidase 3 Yes (mouse)
OTOP1 Otopetrin 1 Yes (mouse)
SLC30A4 Zinc transporter 4 Yes (mouse)
CYBA Cytochrome b-245 light chain (p22-phox) Chronic Granulomatosis Disease Yes (mouse)
PLDN (BLOC1S6) Biogenesis of lysosome-related organelles 
complex 1 subunit 6
Hermansky Pudlak Syndrome 9 Yes (mouse)
PTPRQ Phosphatidylinositol phosphatase PTPRQ DFNB84 Yes (mouse)
OTOF Otoferlin DFNB9 Yes (mouse)
SLC4A11 Sodium bicarbonate transporter-like protein 
11
Corneal Endothelial Dystrophy 
Type 2; Harboyan Syndrome; 
Corneal Dystrophy and 
Perceptive Deafness
Yes (mouse)
Nystagmus reported (human)
Information from Online Mendelian Inheritance in Man (www.omim.org), UniProt (www.uniprot.org), HUGO Gene Nomenclature Committee 
(www.genenames.org), and references cited throughout the text.
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